Experience gained in the use of "Genotropin Pen 5.3" syringe pen in patients with somatotropic insufficiency
https://doi.org/10.14341/probl11581
Abstract
Multidose injection syringe pen "Genotropin Pen 5.3" for subcutaneous injections of recombinant human growth hormone (HGH) was evaluated in 15 patients with somatotropic insufficiency using special questionnaires. The pen proved to be convenient, its new design with an extra cap covering the needle during injection helps reduce the fear and discomfort during injection. The pen is safe and simple to use and is recommended for the treatment of patients with somatotropic insufficiency.
About the Authors
V. A. PeterkovaEndocrinology Research Center RAMS
Russian Federation
N. N. Volevodz
Endocrinology Research Center RAMS
Russian Federation
References
1. Балаболкин М. И. Диабетология. - М., 2000.
2. Дедов И. И., Фадеев В. В. Введение в диабетологию: Руководство для врачей. - М., 1998.
3. Никифоров О. А. Перекисное окисление липидов и система антиоксидантной защиты у больных сахарным диабетом 1 типа: Дис. ... канд. мед. наук. - Новосибирск, 1999.
4. Планирование и проведение клинических исследований лекарственных средств / Под ред. Ю. Б. Белоусова. - М., 2000.
5. Таранов А. Г. Диагностические тест-системы. Радиоиммунный и иммуноферментный методы диагностики. - Новосибирск, 2000.
6. Фадеева Н. И., Балаболкин М. И., Мамаева Г. Г. и др. // Сахарный диабет. - 2001. - № 1. - С. 21-23.
7. Turner R. С. Matthews D R., Clark A. et al. // Baillieres Clin. Endocrinol. Metab. - 1998. - Vol. 12, N 2. - P 327-342.
8. UK Prospective Diabetes Study (UKPDS) Group // Lancet. - 1998. - Vol. 352. - P. 837-853.
Review
For citations:
Peterkova V.A., Volevodz N.N. Experience gained in the use of "Genotropin Pen 5.3" syringe pen in patients with somatotropic insufficiency. Problems of Endocrinology. 2002;48(4):53-54. (In Russ.) https://doi.org/10.14341/probl11581
Views:
4951
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
